Regulatory network between transcription factor, oncogene, histone modification and scgf
GeneAssist Pathway Atlas provides
scgf gene-related interactive pathway maps.
ESCAPE (Embryonic Stem Cells Atlas of Pluripotency Evidence) presents gene-protein interaction database in
ES cells.
(1) NF-κB
Scgf gene is up-regulated when NF-κB is inactivated in HeLa cells by adding tetracyclin (
109), HeLa
tTA/FLAG-1
κBMut cells by depriving doxycyclin (
110) or SHEP-1 neuroblastoma cells by treating with I-κBαM (
179). The
correlation of NF-κB inactivation and
scgf gene up-regulation is compatible with that of umbilical cord blood and
bone marrow CD34
+ cells. NF-κB and
scgf gene is up- and down-regulated, respectively, in umbilical cord blood
CD34
+ cells as compared with bone marrow CD34
+ cells (
38).
Scgf gene expression is highly down-regulated in the RelA
-/- (a component of NF-κB) hES cell-derived MSCs,
and they exhibit defective self-renewal ability (
592). Knockdown of wild type hMSCs with
scgf shRNA abrogates
their proliferative potential, indicating that
scgf is a mandatory driver for MSC proliferation.
Scgf gene expression is highly up-regulated in t(4;14)-positive myeloma cells with
MMSET overexpression.
Knockdown of t(4;14)-positive KMS-26 and NCI-H929 myeloma cells with
scgf siRNA down-regulates expression of
NF-κB, a target for
MMSET, and decreases cell viability by 60% associated with increased annexin V-positive
apoptotic cells (
536).
NF-κB activation as seen in API2-MALT1
+ gastric MALT lymphoma is linked to down-regulation of
scgf gene at
chromosome 19q13.2-q13.4 (
232).
(2) Nrf-2, Nrf1
Nrf-2 (nuclear E2-factor related factor) exhibits cancer chemopreventive effect by binding to antioxidant
response element within the promoter area of detoxic enzyme.
Scgf gene is Nrf-2-dependently up-regulated, i.e.
not in Nrf-2
-/- but in Nrf-2
+/+ mice in the liver when Nrf-2 is activated with sulforaphane (
112) or
phenethylisothiocyanate (
113).
Scgf gene is Nrf-2-dependently down-regulated when Nrf-2 is inactivated with
endoplasmic reticulum stress inducer tunicamycin (
114).
Nrf1
Scgf is a target gene for
Nrf1 (nuclear respiratory factor 1) and also associated with estrogens and estrogen
endocrine disruptors such as bisphenol-A, phthalates and cadmium (
541).
(3) Runx2
Runx2 functions in bone formation associated with neurogenesis and hematopoiesis.
Scgf gene is under control of
runx2 since down-regulated in the bones of runx2
-/- mice as compared with runx2
+/+ mice (
40,
44).
(4) Myc
Ingenuity pathway analysis on doxycyclin-controlled transgenic mice
Eμsrα-tTAmyc discloses
scgf and integrinα
M chain gene regulated by myc (
115).
Scgf promoter is a target bound by Myc-related factors and histone modification in ES, iPS and cancer cells (
274).
Histone modifications of
scgf gene are listed based on ChIP-chip/seq studies in ES cells, iPS cells, MEFs, neural
progenitor cells and whole brain (
ESCAPE; Embryonic Stem Cells Atlas of Pluripotency Evidence).
c-Myc and H3K4me3 binds to
scgf gene promoter in murine epidermal keratinocytes (
353).
H3K4me3 binds to
scgf gene specifically in precursor T cell leukemia cell lines derived from NUP98-PHF23
transgenic mice (
453).
H3K27ac and H3K4me3 bind to
scgf in both rat oligodendrocyte precursor cells and differentiated
oligodendrocytes, while H3K9me3 binds to
scgf in the former cells but not in the latter cells (
461).
Dmap1
(NuA4) |
E2F1 |
E2F4 |
c-Myc |
Max |
n-Myc |
Zfx |
Rex1 |
Tip60 |
Cnot3 |
Trim28 |
AcH3 |
AcH4 |
H3K4me3 |
H3K27ac |
- |
+ |
+ |
+ |
+ |
+ |
- |
- |
- |
- |
- |
+ |
- |
+ |
+ |
+: bound, -: unbound
(5) Stem cell-related factors
None of stem cell-related factors bind to
scgf promoter in ES, iPS and cancer cells (
274,290).
Smad1 |
Stat3 |
Klf4 |
Oct4(Pou5f1) |
Nanog |
Sox2 |
Nac1 |
Zfp281 |
Dax1 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
-: unbound
ChIP-chip/seq analyses demonstrate interaction between
scgf gene and transcription factors in mES cells,
including E2F4, Esrrb, Max, Med1, Med12, Myc, Nipbl, Rcor3, Rest, Rnf2, Smc1A, Smc3, Sox2, Suz12 and Tcf3
(ESCAPE; Embryonic Stem Cells Atlas of Pluripotency Evidence).
Knockdown or overexpression experiment identifies
scgf-regulatory transcription factors in ES cells, including
Ascl2, Klf4, Nr5A2, Smc1A , Sox2 and Tcf3 (
ESCAPE; Embryonic Stem Cells Atlas of Pluripotency Evidence).
Knockdown of
scgf gene expression with
scgf siRNA does not significantly down-regulate
POU5F1 gene promoter
in human H1 ES cells (
285).
Oct4-transduced normal mammary epithelial cells up-regulate
scgf gene expression and acquire cancer stem cell
nature (
345).
(6) TGF-β/Activin/Nodal-Smad2,3-Smad4
BMP-Smad1,5,8-Smad4
Smad2,4 but not Smad1,5 bind to
scgf promoter [chr7:40483523-40483701(178bp)] in mouse ES cells (
290,
291).
Activin up-regulates
scgf gene expression in mouse ES cells (
291).
(7) E2F1
Scgf gene expression is under control of transcription factor E2F1, i.e.
scgf gene is down-regulated 20-fold in the
pancreatic islet cells of E2F1
-/- mouse as compared with wild type controls (
217). E2F1 binds to
scgf promoter in
ES, iPS and cancer cells (
274).
(8) p53
Scgf gene is significantly down-regulated in mutant p53Q373-expressed H1299 and A549 lung cancer cells as
compared with non-mutant p53-expressed cells (
116). p53Q373 suppresses transcription of anti-apoptotic
promoter more efficiently than p53 to induce apoptosis, which is accelerated by down-regulation of
scgf gene.
(9) PU.1
Ets transcription factor PU.1 is encoded by
Sfpi1 gene in mice. PU.1 activates myeloid/B-cell lineage-specific
genes, but represses T/NK-cell lineage-specific genes.
Scgf gene expression is 2.5-fold up-regulated in the IL-3-
dependent myeloid cell line derived from fetal liver cells of
Sfpi1Blac/Blac mice (2% PU.1 of the wild type mice at
protein level) relative to
Sfpi1-/- cells, but returns to the baseline of
Sfpi1-/- cells in
Sfpi1BN/BN cells (20% PU.1)
(224). The PU.1 dose-independent findings indicate that
scgf gene expression is not subject to PU.1
(10) Tcf3, Tbx3
Scgf gene expression is insignificantly affected in the
Tcf3 or
Tbx3 RNAi knockdown ES cells (
233).
(11) Stat3, Stat5
Stat3 but not stat5 regulates
scgf gene expression in CWR22Rv1 human prostate cancer cells (
245). Stat3 does
not bind to
scgf promoter in ES, iPS and cancer cells (
274).
(12) POU4F1
Scgf gene expression is up-regulated in t(8;21)-psitiveAML cells independent on
POU4F1 gene dysregulation (
247)
(13) ATAD2
Scgf gene expression is significantly up-regulated when
ATAD2 gene is knocked down by treating human lung
adenocarcinoma cell line, A549, with an
ATAD2-targeting siRNA (
261).
(14) Polycomb
Scgf promoter is a target for Polycomb-related factors and histone modification in ES, iPS and cancer cells (
274).
Histone modifications of
scgf gene are listed based on ChIP-chip/seq studies in ES cells, iPS cells, MEFs, neural
progenitor cells and whole brain (
ESCAPE; Embryonic Stem Cells Atlas of Pluripotency Evidence).
Scgf gene expression is little affected in undifferentiated and differentiated mouse ES cells lacking H3K4 lysine-
specific demethylase 5A (Kdm5a) compared to Kdm5a
+/+ cells (
391). Kdm2b and Ezh2 but not Ring1b target
scgf
promoter CpG island in the mouse ES cells (
412).
Scgf is a target gene for Ezh2 and ubiquitinated H2AK119
in DU145 prostate cancer cells (
445).
Scgf is a target gene for Cbx7 but not for Cbx8 in the hematopoietic stem cells (
411).
Scgf gene expression is significantly down-regulated in the cumulus cells from older women (>40yr old) relative to younger women (<35yr old). Suz12 is a transcription factor for
scgf (532).
Suz12 |
Eed |
Phc1 |
Rnf2 |
Ezh1 |
Ezh2 |
H3K27me3 |
uH2A |
CTCF |
Cbx7 |
Cbx8 |
Kdm2b |
Kdm5a |
Ring1b |
+ |
+ |
- |
- |
+ |
+ |
- |
+ |
- |
+ |
- |
+ |
+ |
- |
+: bound, -: unbound
(15) HOXB4
Scgf gene expression is up-regulated in
HOXB4-overexpressed c-kit
+Lin
-Sca-1
+ subpopulation of murine EML
primitive hematopoietic cells relative to GFP-expressing vector only EML cells, indicating that
scgf is one of the
"stemness"-specific target genes of HOXB4 (
315).
(16) Notch1
When Notch1 signaling is inhibited in rat aortic valve interstitial cells by Γ-secretase inhibitor,
scgf gene
expression is down-regulated (
347).
(17) Wnt3a, Wnt5a
Transduction of mouse BM stromal OP9 cells with wnt3a alters their mesenchymal stem cell characteristics into
that of osteoblasts, and extremely up-regulates
scgf gene expression in addition to decorin, fibromodulin and
tenascin (
361). Wnt5a gene is specifically up-regulated in the osteoblasts differentiated from MSCs.
Scgf gene is
down-regulated in the calvaria of
wnt5a-/- mice as compared with that of
wnt5a+/+ mice (
43).
(18) Per1
Circadian clock
Per1 gene maintains murine CD34
+Α6 integrin
brightPer1-venus
bright hair follicle epidermal
stem cells dormant, where
scgf gene expression is up-regulated relative to the Per1-venus
dim stem cells (
352).
(19) Lamin-B1
Lamin-B1 binding to
scgf gene promoter is significantly up-regulated in murine trophectoderm cells compared
with ES cells (
357).
(20) Histone deacetylase (HDAC)
Trichostatin A, a potent HDAC inhibitor, up-regulates
scgf gene expression in F9 mouse embryonal carcinoma cells
(275) and BE(2)-C neuroblastoma cells (
283).
(21) Etv6, Pax6
Scgf gene is bound by Etv6 but not Pax6 in the mouse NSEB5-2C neural progenitor cells even after iPSC
induction (
416).
(22) EWS
Scgf gene is usually up-regulated in Ewing family tumor (one of small round blue tumor associated with EWS/FLI1
translocation is estimated to be originated in tumorigenesis between neural crest from neural ectoderm and
mesenchymal-vascular endothelial lineage) (
154,249).
EWS-FLI1 binds to the (GGAA)n microsatellite (Chr19:55933752-55934360) of
scgf gene promoter, and activates
transcription (
278).
(23) Cyclin D1
Cyclin D1 binds to
scgf promoter (Chr7:40478877-40478922) in the retina from
cyclin D1-knockin mouse, possibly
regulating
scgf gene expression, but retinas from
cyclin D1-knockout (
Ccnd1-/-) mouse show no significant change
in
scgf gene expression as compared to wild type controls (
281).
(24) Argonaute
Argonaute (AGO) 2 binds to
scgf gene promoter in RAS
V12-induced senescent primary WI38 fibroblasts, but not
in presenescent control cells (
364).
(25) MMSET/WHSC1
Myeloma cells with t(4;14)(p16.3;q32) overexpress gene network between
MMSET/WHSC1,
FGFR3 and
scgf (
365).
(26) Bre1, histone H2B ubiquitin ligase
Deletion of histone H2B ubiquitin ligase
Bre1 by RNAi down-regulates
scgf gene expression in mouse fibrosarcoma
RIF-1 cells (
367).
(27) CREB
Scgf gene expression is down-regulated in the CREB-overexpressed nucleus accumbens shell of socially isolated
adult rats (
390).
(28) BRIP1
Scgf gene expression is up-regulated in normal mammary epithelial MCF-10A cells when BRCA1-interacting
helicase BRIP1 is knocked down (
426).
(29) DNA methyltransferase (Dnmt1, Dnmt3a, Dnmt3b)/DNA methylation
Differentiation of epidermal progenitor cells to keratinocytes down-regulates DNA methyltransferase 1 (Dnmt1)
gene expression, along which
scgf gene is somewhat up-regulated and loses methylation (
280). However Dnmt1
knockdown with Dnmt1 shRNA little affects
scgf gene expression.
Scgf gene expression is down-regulated in Dnmt3a-knockout (KO) mouse HSCs but up-regulated in Dnmt3a/
Dnmt3b-double KO HSCs, while most genes show no dissociated regulation between Dnmt3a-KO and Dnmt3a/
Dnmt3b-double KO HSCs (
471).
Scgf gene expression is up-regulated in the ITGα6
+ epidermal tumor cells from
conditional Dnmt3a-KO mice treated with DMBA and TPA (
560).
Methylome analysis on hematopoietic progenitors indicates that CpG sites in the
scgf promoter are differentially
methylated between Lin
-Il7ra
-c-Kit
+Sca-1
+CD34
+Flt3
+ multipotent progenitors (MPP) and Lin
-CD27
+Flt3
+Il7ra
+
Ly6D
- common lymphoid progenitors (CLP) (MPP>CLP), between CLP and Lin
-CD4
-CD8
-c-Kit
+CD44
+CD25
-
thymocyte progenitors (DN1) (DN1>CLP), and between DN1 and Lin
-CD4
-CD8
-c-Kit
+CD44
+CD25
+ thymocyte
progenitors (DN2) (DN1>DN2) (
284).
CpG sites of
scgf gene promoter are differentially hypomethylated in the pediatric ALL cells at relapse as
compared to the matched cells at diagnosis (
344).
Scgf gene is differentially expressed and methylated in pediatric
ALL cells compared to normal CD19
+ cells (
617). Prenatal maternal exposure to low levels of lead induces
hypomethylation of CpG site cg10773601 upstream to
scgf gene in the newborn umbilical cord blood cells (
564).
Dcitabine significantly demethylates
scgf gene promoter in MLL5
+ mouse BM cells relative to MLL5
- cells (
470).
Scgf gene in peripheral blood mononuclear cells from healthy 1 year old child shows a significant gain in DNA
methylation relative to cord blood mononuclear cells from the same child (
182).
Scgf gene is hypermethylated in the ovary from neonatal rats exposed to high dose of pesticide methoxychrol
during fetal and neonatal stages (
406).
Scgf is one of the genes within partially methylated domains of genome DNA from human placenta (
415).